Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the
- This topic has 0 replies, 1 voice, and was last updated 2 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway
https://pubmed.ncbi.nlm.nih.gov/34440089/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.